Access Oncology Licenses Zentaris’ Anticancer Compound

By Business Review Editor

Pharma Deals Review: Vol 2002 Issue 29 (Table of Contents)

Published: 2 Oct-2002

DOI: 10.3833/pdr.v2002.i29.993     ISSN: 1756-7874

Section: Licensing



Access Oncology and Zentaris AG, a subsidiary of Degussa AG entered into licensing and co-development agreement for Zentaris’ perifosine for the treatment of tumors...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details